Medigen Vaccine Biologics Corporation

TPEX:6547 Stock Report

Market Cap: NT$12.4b

Medigen Vaccine Biologics Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Leo Lee

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureless than a year
CEO ownershipn/a
Management average tenureno data
Board average tenure1.5yrs

Recent management updates

Recent updates

We're Hopeful That Medigen Vaccine Biologics (GTSM:6547) Will Use Its Cash Wisely

Mar 31
We're Hopeful That Medigen Vaccine Biologics (GTSM:6547) Will Use Its Cash Wisely

Would Medigen Vaccine Biologics (GTSM:6547) Be Better Off With Less Debt?

Dec 15
Would Medigen Vaccine Biologics (GTSM:6547) Be Better Off With Less Debt?

CEO

Leo Lee

less than a year

Tenure

Leo Lee is Chief Executive Officer of Medigen Vaccine Biologics Corporation.

Board Members

NamePositionTenureCompensationOwnership
Chia-Hsiu Lin
Directorless than a yearNT$322.00kno data
Ming Cheng Chang
Chairman9.3yrsNT$322.00kno data
Tsan-Chien Chen
Director12yrsno datano data
Yao-Chi Li
Independent Director6.5yrsNT$312.00kno data
Ming-Yi Wu
Independent Director1.5yrsno datano data
Chin-Yen Chen
Representative Directorless than a yearno datano data
Peng-Fei Su
Independent Directorless than a yearno data0.070%
NT$ 8.7m

1.5yrs

Average Tenure

Experienced Board: 6547's board of directors are not considered experienced ( 1.5 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/28 18:43
End of Day Share Price 2024/12/27 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Medigen Vaccine Biologics Corporation is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Hsuan ChenKGI Securities Co. Ltd.
Yijun ChenSinoPac Securities Investment Service